01 Home 02 About 03 Products 04 Manufacturing 05 Research 06 Global 07 Sustainability 08 Careers 09 News 10 Contact
Legal

Privacy, in
plain language.

We collect what you send us, we use it to answer you, and we do not sell it to anyone. Everything below is the longer version of those three facts.

Privacy Policy

Last updated: 17 July 2026

This policy is written to be read, not to be survived. If any part of it is unclear, write to privacy@nssonspharma.com and we will explain it in plain language.

01

What we collect

When you contact us through this site we collect the information you choose to give us — typically your name, email address, organisation, country and the content of your message. We do not collect more than that, and we do not buy data about you from anyone else.

02

Why we collect it

To answer you. That is the whole purpose. If you submit a careers application we retain it so we can consider you for the role you applied to and for others that may suit you better. If you report an adverse event, we are legally required to record and, in defined circumstances, forward that report to the Drug Regulatory Authority of Pakistan.

03

What we do not do

We do not sell your information. We do not share it with advertisers or data brokers. We do not add you to a marketing list because you asked a question — if you subscribe to our updates, that is a separate and explicit choice you make.

04

How long we keep it

General enquiries are retained for two years. Careers applications are retained for three years unless you ask us to remove them sooner. Pharmacovigilance records are retained for the period required by pharmaceutical regulation, which is considerably longer and is not within our discretion.

05

Cookies

This site uses no advertising cookies, no third-party trackers and no analytics that profile you across other sites. Fonts and photography are loaded from third-party providers (Google Fonts, Fontshare and Unsplash), which may receive your IP address as a technical consequence of serving those files.

06

Your rights

You may ask us what we hold about you, ask us to correct it, or ask us to delete it — except where retention is mandated by pharmaceutical regulation, in which case we will tell you plainly which record we cannot remove and why. Write to privacy@nssonspharma.com and we will respond within thirty days.

07

Security

Enquiry data is held on access-controlled systems available only to the people who need it to do their job. We are not going to claim this makes it unbreakable, because no honest organisation can claim that. If a breach affects you, we will tell you.

Terms of Use

The small print,
written large.

01

Information on this site

The content here is provided for general information. Product information is not a substitute for the approved prescribing information in your market — availability, strengths and registration status vary by country, and the locally approved summary of product characteristics always takes precedence.

02

Not medical advice

Nothing on this site constitutes medical advice, diagnosis or a recommendation to use any product. Decisions about treatment belong to a qualified healthcare professional who knows the patient.

03

Forward-looking statements

Pipeline stages, commitment dates and capacity projections are estimates, subject to regulatory review, study outcomes and manufacturing readiness. Nothing on this site should be read as a guarantee of a launch date or an outcome.

04

Intellectual property

Brand names, logos and site content are the property of NS-Sons Pharmaceuticals Pvt Ltd unless otherwise stated. Photography on this site may be licensed from third-party providers.

05

External links

Where we link to another organisation's site, we are not responsible for its content or its privacy practices.

Reporting a safety concern

If you have experienced or observed a suspected adverse reaction to an NS-Sons product, please report it to pv@nssonspharma.com or call +92 21 3506 0099, monitored 24 hours a day. An incomplete report is far better than no report — full reporting guidance